Reviva Pharmaceuticals Holdings Inc (RVPH)
3.20
+0.02
(+0.63%)
USD |
NASDAQ |
May 03, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Shareholders Equity (Quarterly): 5.719M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.719M |
September 30, 2023 | -8.519M |
June 30, 2023 | 1.621M |
March 31, 2023 | 5.785M |
December 31, 2022 | 8.394M |
September 30, 2022 | 20.36M |
June 30, 2022 | 16.06M |
Date | Value |
---|---|
March 31, 2022 | 21.36M |
December 31, 2021 | 28.69M |
September 30, 2021 | 32.27M |
June 30, 2021 | 34.52M |
March 31, 2021 | 4.516M |
December 31, 2020 | 5.466M |
November 30, 2020 | 29.65M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.519M
Minimum
Sep 2023
34.52M
Maximum
Jun 2021
14.71M
Average
12.23M
Median
Shareholders Equity (Quarterly) Benchmarks
AbbVie Inc | 8.007B |
ABVC BioPharma Inc | 8.388M |
Sutro Biopharma Inc | 149.65M |
Flora Growth Corp | 6.404M |
Journey Medical Corp | 20.35M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.70M |
Total Liabilities (Quarterly) | 17.98M |